Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

OncoGenex and Isis collaborate on antisense drug for prostate and other cancers

Nov. 28, 2001

Active Biotech signs benzamide licensing agreement with Oxigene

Nov. 28, 2001

Antitumor and antimetastatic effects demonstrated in new series from Ishihara Sangyo

Nov. 27, 2001

AstraZeneca to return development rights for ZD-0473 to AnorMED

Nov. 27, 2001

Matrix seeks approval for IntraDose in Europe

Nov. 27, 2001

Protein tyrosine kinase inhibitors from AHP exert antitumor activity in vitro

Nov. 26, 2001

Antitumor sulfonamide derivatives reported in recent patent by Sankyo

Nov. 26, 2001

Specific inhibition of MMP-2 binding to alphavbeta3 integrin for inhibiting angiogenesis

Nov. 26, 2001

Design and biological activity of new camptothecin glycoconjugates described by Bayer

Nov. 26, 2001

Inhibitors of certain receptor tyrosine kinases in early development at Celltech

Nov. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...